Analysts expect Medidata Solutions Inc (NASDAQ:MDSO) to announce $0.36 earnings per share for the current quarter, according to Zacks. Six analysts have issued estimates for Medidata Solutions’ earnings, with the highest EPS estimate coming in at $0.46 and the lowest estimate coming in at $0.29. Medidata Solutions posted earnings of $0.41 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 12.2%. The company is scheduled to issue its next earnings report on Thursday, February 14th.

According to Zacks, analysts expect that Medidata Solutions will report full-year earnings of $1.63 per share for the current financial year, with EPS estimates ranging from $1.54 to $1.72. For the next fiscal year, analysts expect that the company will report earnings of $1.85 per share, with EPS estimates ranging from $1.67 to $2.00. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Medidata Solutions.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Thursday, October 18th. The company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.06. The company had revenue of $163.41 million during the quarter, compared to the consensus estimate of $162.09 million. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.33 earnings per share.

MDSO has been the subject of several analyst reports. Piper Jaffray Companies reduced their price target on shares of Medidata Solutions from $96.00 to $93.00 in a research report on Thursday, October 18th. ValuEngine raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. BidaskClub downgraded shares of Medidata Solutions from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 5th. Royal Bank of Canada set a $98.00 price target on shares of Medidata Solutions and gave the company a “buy” rating in a research report on Tuesday, July 24th. Finally, Morgan Stanley set a $84.00 target price on shares of Medidata Solutions and gave the stock a “hold” rating in a research report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $84.64.

Shares of MDSO opened at $70.94 on Friday. The company has a market cap of $4.29 billion, a P/E ratio of 83.46, a PEG ratio of 4.14 and a beta of 1.30. The company has a quick ratio of 2.52, a current ratio of 2.52 and a debt-to-equity ratio of 0.15. Medidata Solutions has a twelve month low of $59.60 and a twelve month high of $88.87.

In related news, EVP Michael I. Otner sold 7,030 shares of Medidata Solutions stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the transaction, the executive vice president now owns 62,548 shares in the company, valued at approximately $4,340,831.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 4.70% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Man Group plc purchased a new position in shares of Medidata Solutions during the 3rd quarter valued at $205,000. Quantbot Technologies LP purchased a new stake in Medidata Solutions in the 3rd quarter worth $229,000. World Asset Management Inc purchased a new stake in Medidata Solutions in the 2nd quarter worth $235,000. Zeke Capital Advisors LLC purchased a new stake in Medidata Solutions in the 2nd quarter worth $239,000. Finally, First Republic Investment Management Inc. purchased a new stake in Medidata Solutions in the 2nd quarter worth $242,000.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

See Also: What are earnings reports?

Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.